Giampaolo Merlini, M.D. (page 2)

Dr. Merlini’s main research interests are the pathogenesis, natural history, diagnosis and treatment of monoclonal gammapathies, in particular immunoglobulin light chain amyloidosis. Recently his research has focused on the investigation of biomarkers for assessing prognosis and response to therapy and on the development of novel therapeutic agents and treatment designed in the light of advances in the understanding of the molecular mechanisms of these diseases. He is, and has been, principal investigator for several research projects in this field funded by the European Community and national research agencies. Dr. Merlini lectures widely and has written more than 300 articles, books, book chapters and reviews. Dr. Merlini’s contribution to the field of Waldenström’s macroglobulinemia spans from the investigation of the antibody activities of the monoclonal IgMs to the definition of the prognosis and treatment guidelines, and development of new therapeutic avenues. He was instrumental in establishing an international collaboration to define a new prognostic scoring system for Waldenström s macroglobulinemia.

Click this link for WM clinical trials under Dr. Merlini.

Contact Info:
Giampaolo Merlini, MD
IRCCS Policlinico San Matteo Hospital
University of Pavia
Viale Golgi 19
27100 Pavia - PV, Italy
+39-0382-502490
+39-0382-502999 (fax)
Email: gmerlini@unipv.it